Cargando…

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial

Annual fecal immunochemical testing (FIT) is cost‐effective for colorectal cancer (CRC) screening. However, FIT positivity rates and positive predictive value (PPV) can vary substantially, with false‐positive (FP) results adding to colonoscopy burden without improving cancer detection. Our objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielson, Carrie M., Petrik, Amanda F., Jacob, Lorie, Vollmer, William M., Keast, Erin M., Schneider, Jennifer L., Rivelli, Jennifer S., Kapka, Tanya J., Meenan, Richard T., Mummadi, Rajasekhara R., Green, Beverly B., Coronado, Gloria D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144161/ https://www.ncbi.nlm.nih.gov/pubmed/30101513 http://dx.doi.org/10.1002/cam4.1727

Ejemplares similares

Analytic Challenges Arising from the STOP CRC Trial: Pragmatic Solutions for Pragmatic Problems
por: Vollmer, William M., et al.
Publicado: (2015)

Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches
por: Coronado, Gloria D., et al.
Publicado: (2017)

Using an Automated Data-driven, EHR-Embedded Program for Mailing FIT kits: Lessons from the STOP CRC Pilot Study
por: Coronado, Gloria D., et al.
Publicado: (2014)

Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes
por: Coronado, Gloria D, et al.
Publicado: (2014)

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial
por: O’Connor, Elizabeth A., et al.
Publicado: (2020)

Challenges in assessing population reach in a pragmatic trial
por: Green, Beverly B., et al.
Publicado: (2019)

Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process
por: Coronado, Gloria D., et al.
Publicado: (2021)

Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening
por: O’Connor, Elizabeth A., et al.
Publicado: (2020)

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics
por: Coury, Jennifer, et al.
Publicado: (2017)

Effectiveness of automated and live phone reminders after mailed-FIT outreach in a pilot randomized trial
por: Nielson, Carrie M., et al.
Publicado: (2018)

The use of individual and multilevel data in the development of a risk prediction model to predict patients’ likelihood of completing colorectal cancer screening
por: Petrik, Amanda F., et al.
Publicado: (2023)

Increasing Fecal Immunochemical Test Return Rates by Implementing Effective “Reminder to Complete Kit” Communication With Participants: A Quality Improvement Study
por: Prakash, Sameer, et al.
Publicado: (2022)

Why does diabetic retinopathy happen, and how can we stop it?
por: Ockrim, Zoe
Publicado: (2011)

A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers
por: Thompson, Jamie H., et al.
Publicado: (2019)

Factors predicting improved compliance towards colonoscopy in individuals with positive faecal immunochemical test (FIT)
por: Lim, Tian‐Zhi, et al.
Publicado: (2021)

Precision Patient Navigation to Improve Rates of Follow-up Colonoscopy, An Individual Randomized Effectiveness Trial
por: Coronado, Gloria D., et al.
Publicado: (2021)

First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders
por: Baldwin, Laura-Mae, et al.
Publicado: (2020)

Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model
por: Fisher, Deborah A., et al.
Publicado: (2020)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions
por: Baxter, Nielson T., et al.
Publicado: (2016)

Impact of time between faecal immunochemical tests in colorectal cancer screening on screening results: A natural experiment
por: Ribe, Sara G., et al.
Publicado: (2022)

Participant uptake of the fecal immunochemical test decreases with the two-sample regimen compared with one-sample FIT
por: Mosen, David M., et al.
Publicado: (2014)

Descriptive Study of Prescriptions for Opioids from a Suburban Academic Emergency Department Before New York’s I-STOP Act
por: Ung, Lyncean, et al.
Publicado: (2015)

A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago
por: Schneider, John A., et al.
Publicado: (2021)

Mailed fecal testing and patient navigation versus usual care to improve rates of colorectal cancer screening and follow-up colonoscopy in rural Medicaid enrollees: a cluster-randomized controlled trial
por: Coronado, Gloria D., et al.
Publicado: (2022)

DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model
por: Baxter, Nielson T., et al.
Publicado: (2016)

Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program
por: Green, Beverly B., et al.
Publicado: (2020)

Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics
por: Petrik, Amanda F., et al.
Publicado: (2020)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Hemodynamic Gain Index Is Associated With Cardiovascular Mortality and Improves Risk Prediction: A PROSPECTIVE COHORT STUDY
por: Laukkanen, Jari A., et al.
Publicado: (2023)

Performance of the Fecal Immunochemical Test in Patients With a Family History of Colorectal Cancer
por: Moosavi, Sarvee, et al.
Publicado: (2019)

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study
por: Pavlović, Jelena, et al.
Publicado: (2017)

Source matters: a survey of cost variation for fecal immunochemical tests in primary care
por: Coury, Jennifer, et al.
Publicado: (2022)

Barriers and facilitators to participation in a health check for cardiometabolic diseases in primary care: A systematic review
por: de Waard, Anne-Karien M, et al.
Publicado: (2018)

Direct‐to‐member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study
por: Coronado, Gloria D., et al.
Publicado: (2019)

Immunochemical protocols
Publicado: (1998)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Risk of cancer in patients with fecal incontinence
por: Adelborg, Kasper, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4iitt4cgk7snbodghir284fco9